- Home
- RPRX vs ESS Comparison
RPRX vs ESS Comparison
Compare RPRX & ESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- ESS
- Stock Information
- Founded
- RPRX 1996
- ESS 1971
- Country
- RPRX United States
- ESS United States
- Employees
- RPRX N/A
- ESS N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- ESS Real Estate Investment Trusts
- Sector
- RPRX Health Care
- ESS Real Estate
- Exchange
- RPRX Nasdaq
- ESS Nasdaq
- Market Cap
- RPRX 15.6B
- ESS 17.0B
- IPO Year
- RPRX 2020
- ESS 1994
- Fundamental
- Price
- RPRX $35.15
- ESS $264.47
- Analyst Decision
- RPRX Strong Buy
- ESS Hold
- Analyst Count
- RPRX 3
- ESS 18
- Target Price
- RPRX $45.33
- ESS $299.68
- AVG Volume (30 Days)
- RPRX 3.9M
- ESS 366.0K
- Earning Date
- RPRX 11-05-2025
- ESS 10-28-2025
- Dividend Yield
- RPRX 2.50%
- ESS 3.88%
- EPS Growth
- RPRX 54.86
- ESS 54.17
- EPS
- RPRX 2.32
- ESS 12.44
- Revenue
- RPRX $2,305,243,000.00
- ESS $1,887,957,000.00
- Revenue This Year
- RPRX $33.77
- ESS $3.91
- Revenue Next Year
- RPRX $4.62
- ESS $3.75
- P/E Ratio
- RPRX $15.12
- ESS $21.29
- Revenue Growth
- RPRX 3.02
- ESS 9.79
- 52 Week Low
- RPRX $24.05
- ESS $243.85
- 52 Week High
- RPRX $38.00
- ESS $317.73
- Technical
- Relative Strength Index (RSI)
- RPRX 40.78
- ESS 48.06
- Support Level
- RPRX $35.97
- ESS $263.00
- Resistance Level
- RPRX $36.94
- ESS $270.13
- Average True Range (ATR)
- RPRX 0.85
- ESS 4.43
- MACD
- RPRX -0.06
- ESS 0.62
- Stochastic Oscillator
- RPRX 33.46
- ESS 47.64
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 257 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.